Integra Lifesciences Holdings (IART) Other financing activities (2009 - 2025)

Integra Lifesciences Holdings (IART) has 17 years of Other financing activities data on file, last reported at $957000.0 in Q1 2025.

• For the quarter ending Q1 2025, Other financing activities fell 85.04% year-over-year to $957000.0; the trailing twelve-month figure through Dec 2025 stood at $957000.0 (down 85.04% YoY), and the FY2025 full-year result was $957000.0, down 85.04% from the prior year.
• Other financing activities eased to $957000.0 in Q1 2025, from $6.4 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $6.4 million in Q1 2024 to a low of $225000.0 in Q4 2023.
• A 5-year average of $1.8 million and a median of $1.2 million in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities plunged 99.42% in 2021 and soared 1541.1% in 2022, its largest moves.
• Tracing IART's Other financing activities over 5 years: stood at $236000.0 in 2021, then soared by 1541.1% to $3.9 million in 2022, then plunged by 94.19% to $225000.0 in 2023, then jumped by 2743.56% to $6.4 million in 2024, then plunged by 85.04% to $957000.0 in 2025.
• Business Quant data shows IART's Other financing activities at $957000.0 in Q1 2025, $6.4 million in Q1 2024, and $225000.0 in Q4 2023.